Management of allogeneic stem cell transplantation for high-risk AML following SARS-CoV-2 associated pancytopenia with marked bone marrow biopsy alterations

Kaparou, M., Rudzki, Z., Giles, H. et al. (16 more authors) (2021) Management of allogeneic stem cell transplantation for high-risk AML following SARS-CoV-2 associated pancytopenia with marked bone marrow biopsy alterations. Case Reports in Hematology, 2021. 8843063. ISSN 2090-6560

Abstract

Metadata

Authors/Creators:
  • Kaparou, M.
  • Rudzki, Z.
  • Giles, H.
  • Murthy, V.
  • Srinath, S.
  • Lloyd, R.
  • Ahmed, M.Z.
  • Salhan, B.
  • Chauhan, S.
  • Kishore, B.
  • Lovell, R.
  • Horgan, C.
  • Paneesha, S.
  • Xenou, E.
  • Lokare, A.
  • Ewing, J.
  • Dassanayake, H.
  • Nikolousis, E.
  • Kanellopoulos, A.
Copyright, Publisher and Additional Information: © 2021 Maria Kaparou et al. This is an open access article distributed under the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Accepted: 14 January 2021
  • Published (online): 22 January 2021
  • Published: 22 January 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Academic Unit of Medical Education (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 21 Feb 2022 18:32
Last Modified: 22 Feb 2022 09:42
Status: Published
Publisher: Hindawi Limited
Refereed: Yes
Identification Number: https://doi.org/10.1155/2021/8843063
Related URLs:

Share / Export

Statistics